Rebuttal to Dr Streiner: can the "evil" in the "lesser of 2 evils" be justified in placebo-controlled trials?
Glass
Kathleen Cranley
KC
Biomedical Ethics Unit, Associate Professor, Departments of Human Genetics and Pediatrics, McGill University Faculty of Medicine, Montreal, Quebec. kathleen.glass@mcgill.ca
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004995:Ethics, Professional; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011570:Psychiatry / Q000941:ethics*; D011600:Psychopharmacology / Q000941:ethics*; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*
D014150:Antipsychotic Agents